[1]
Shahverdi, E. et al. 2026. Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors: A Narrative Clinical Review. Asian Pacific Journal of Cancer Biology. 11, 2 (Jun. 2026), 695–703. DOI:https://doi.org/10.31557/APJCB.2026.11.2.695-703.